Dr. David R. Fogelman, MD
- Medicare services, 2020
- 97
- Part D claims, 2020
- 66
- Publications
- 122
- Clinical trials
- 5
- Industry payments
- $4,504
- Practice address
- 6445 Main St Ste 2500 Suite 2500, Houston, TX 77030
- Practice phone
- Call (713) 441-9000
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Houston Methodist Physician Organization - Houston (Main St)
Multi-specialty group site · Houston, Texas
Find Dr. Fogelman's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. David R. Fogelman is a hematologist and oncologist in Ann Arbor, Michigan
Dr. Fogelman practices at Houston Methodist Physician Organization - Houston (Main St) in Houston, Texas.
Dr. Fogelman's NPI, 1811918634, was assigned on July 21, 2006. Dr. Fogelman graduated from Albert Einstein College of Medicine in 1998. Dr. Fogelman holds Texas license M6616.
- NPI
- 1811918634NPI Registry (opens in a new tab)
- NPI enumeration date
- July 21, 2006
- NPI status
- Active
- Practice phone
- (713) 441-9000
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Medical school graduation
- 1998
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. David R. Fogelman practices in Houston and Ann Arbor
Dr. Fogelman's primary practice is Houston Methodist Physician Organization - Houston (Main St), at 6445 Main St Ste 2500 Suite 2500, Houston, TX 77030. The practice phone is (713) 441-9000. The NPI Registry lists Dr. Fogelman's practice address as 1500 E Medical Center Dr, Ann Arbor, MI 48109.
- Houston Methodist Physician Organization - Houston (Main St)Primary6445 Main St Ste 2500 Suite 2500, Houston, TX 77030Phone(713) 441-9000
- NPI Registry address1500 E Medical Center Dr, Ann Arbor, MI 48109 · Washtenaw CountyPhone(713) 792-2828
Sources: NPPES NPI Registry (CMS); Dmand AI Affiliation Data; Doctors and Clinicians National Downloadable File (CMS); and Dmand AI Practice Data
Dr. David R. Fogelman is affiliated with 1 site of care and 1 medical group
Dr. Fogelman's primary practice is Houston Methodist Physician Organization - Houston (Main St) in Houston, Texas. The medical group on file is Houston Methodist.
Sources: Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dmand AI tracks the EHR system at Dr. David R. Fogelman's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Fogelman practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Houston Methodist Physician Organization - Houston (Main St) | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. David R. Fogelman is one of 298 hematologists and oncologists in Michigan
Hematology and oncology is Dr. Fogelman's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Fogelman is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Fogelman's licenses on file in 3 states: Texas, New York and Oklahoma.
Specialties and state licenses
- Hematology and oncology, TexasPrimary
- New York license
- Oklahoma license
Hematologists and oncologists near Dr. Fogelman
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. David R. Fogelman billed Medicare for 97 services in 2020
CMS data shows 97 Medicare services from Dr. Fogelman across 2 procedure codes in 2020, all of them office visits. Medicare paid $4,352 for them. Every service was in a facility, such as a hospital, rather than an office.
Dr. Fogelman's Medicare services by type, 2019 to 2020
- 2019
- 2020
- Office and hospital visits
- 2019: 4002020: 9776%
Dr. Fogelman compared with the Michigan median for hematologists and oncologists, 2020
- Dr. Fogelman
- Michigan median
- Medicare services
- 97vs 61984% below
- Part D claims
- 66vs 37883% below
Medians across 291 hematologists and oncologists in Michigan with Dmand AI profiles that report each measure.
Dr. Fogelman's most billed Medicare procedure codes, 2020
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Fogelman?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Fogelman and other hematologists and oncologists in Michigan.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. David R. Fogelman's patients have a median age of 74
Across all payers, Dmand AI patient panel data puts Dr. Fogelman's median patient age at 74, with 50% women.
Dr. Fogelman's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 74
Patient panel by sex, all payers
- Women50%
- Men50%
Source: Dmand AI Patient Panel Data
Dr. David R. Fogelman wrote 66 Medicare Part D claims in 2020
In 2020, Dr. Fogelman wrote 66 Medicare Part D claims. They cover 3 drugs, with $50,230 in total drug cost. In 2019, CMS named 154 claims across 7 drugs.
Dr. Fogelman's most prescribed drugs by claims, 2020
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2019 to 2020
- 2019
- 2020
- Claims for drugs CMS names
- 2019: 1542020: 6657%
Drugs named by CMS: 3 in 2020, 7 in 2019.
Source: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. David R. Fogelman has 122 publications on record
Dmand AI links 122 papers to Dr. Fogelman, published from 2008 to 2025. 2019 was the busiest year, with 15. The most frequent topics are Pancreatic Neoplasms, Antineoplastic Combined Chemotherapy Protocols and Adenocarcinoma. Dr. Fogelman has published most often in Ann Surg Oncol. Dr. Fogelman's most frequent co-authors are Milind Javle, MD, Robert A. Wolff, MD and Michael J. Overman, MD.
Dr. Fogelman's papers by year, 2016 to 2025
Topics Dr. Fogelman writes about most
- Pancreatic Neoplasms
- Antineoplastic Combined Chemotherapy Protocols
- Adenocarcinoma
- Colorectal Neoplasms
- Deoxycytidine
- Gemcitabine
- Carcinoma, Pancreatic Ductal
- Antibodies, Monoclonal, Humanized
Dr. Fogelman's most frequent co-authors
- Milind Javle, MD39 shared papers
- Robert A. Wolff, MD31 shared papers
- Michael J. Overman, MD23 shared papers
Recent publications by Dr. Fogelman
See who Dr. Fogelman researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Fogelman works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. David R. Fogelman has worked on 5 clinical trials
Dmand AI links Dr. Fogelman to 5 clinical trials, 2 of them phase 2 studies. 1 is still active or recruiting. Conditions studied include Pancreatic Neoplasms, Pancreatic Diseases and Neoplasms, Squamous Cell. M.D. Anderson Cancer Center sponsors the most, 3. Open Payments lists research payments to Dr. Fogelman that name 1 trial.
Clinical trials with Dr. Fogelman by phase
- 1Phase 1: 1 trial
- 2Phase 2: 2 trials
- 1Phase 3: 1 trial
- NonePhase 4: no trials
Conditions in Dr. Fogelman's trials
- Pancreatic Neoplasms
- Pancreatic Diseases
- Neoplasms, Squamous Cell
- Squamous Cell Carcinoma of Head and Neck
Investigators on the most trials with Dr. Fogelman
Recent clinical trials with Dr. Fogelman
Binimetinib Plus Hydroxychloroquine in KRAS Mutant Metastatic Pancreatic Cancer (opens in a new tab)
Sources: Open Payments (CMS), 2025 data, released July 7, 2026; Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. David R. Fogelman received $4,504 in industry payments from 2016 to 2020
CMS Open Payments shows 18 general payments to Dr. Fogelman from 7 drug and device companies from 2016 to 2020. Travel and lodging make up the largest share, 45% of the total. Halozyme Inc paid the most, $2,268. It also lists 1 research payment totaling $102 in 2020, naming 1 clinical trial.
General payments to Dr. Fogelman by program year, 2016 to 2020
General payments to Dr. Fogelman by kind, 2016 to 2020
- Travel and lodging$2,01545%
- Speaker and faculty fees$1,50033%
- Food and beverage$91320%
- Education$762%
Companies that paid Dr. Fogelman the most, 2016 to 2020
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. David R. Fogelman graduated from Albert Einstein College of Medicine
Dr. Fogelman graduated from Albert Einstein College of Medicine in 1998.
- Medical school
- Board certified in internal medicine
- Board certified in medical oncology
Source: Dmand AI Professional Profile Data
Sources for Dr. David R. Fogelman's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Affiliation DataDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Dmand AI Practice Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. David R. Fogelman
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. David R. Fogelman's NPI number?
Dr. David R. Fogelman's NPI number is 1811918634. It was assigned on July 21, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. David R. Fogelman?
Dr. David R. Fogelman is a hematologist and oncologist in Ann Arbor, Michigan. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. David R. Fogelman practice?
Dr. Fogelman practices at 6445 Main St Ste 2500 Suite 2500, Houston, TX 77030. Dr. Fogelman also practices at 1500 E Medical Center Dr, Ann Arbor, MI 48109. Dr. Fogelman's primary practice is Houston Methodist Physician Organization - Houston (Main St) in Houston, Texas.
What is Dr. David R. Fogelman's office phone number?
The practice phone on file for Dr. Fogelman is (713) 441-9000.
What is Dr. David R. Fogelman's medical license number?
Dr. Fogelman holds Texas license M6616, one of the licenses on file in 3 states.
Which states has Dr. David R. Fogelman been licensed in?
Dmand AI has state licenses on file for Dr. Fogelman in Texas (2007 to 2026), New York and Oklahoma (2020 to 2021).
What medical group is Dr. David R. Fogelman part of?
Dr. Fogelman is linked to Houston Methodist.
Does Dr. David R. Fogelman accept Medicare?
Yes. CMS data shows Dr. Fogelman billed Medicare for 97 services in 2020.
Is Dr. David R. Fogelman board certified?
Yes. Dr. Fogelman is board certified in internal medicine by the American Board of Internal Medicine.
What services does Dr. David R. Fogelman bill to Medicare?
In 2020, Dr. Fogelman's most billed Medicare services were office visit, established patient (99214) and office visit, established patient (99213).
Show 6 more questionsShow fewer questions
Where did Dr. David R. Fogelman go to medical school?
Dr. Fogelman graduated from Albert Einstein College of Medicine in 1998.
What drugs does Dr. David R. Fogelman prescribe most?
In 2020 Medicare Part D data, Dr. Fogelman's most prescribed drugs by claims were Creon, Ondansetron HCl and Dexamethasone.
Has Dr. David R. Fogelman received payments from drug or device companies?
CMS Open Payments shows $4,504 in general payments to Dr. Fogelman from 7 companies from 2016 to 2020. The largest total came from Halozyme Inc.
How long has Dr. David R. Fogelman been practicing?
Dr. Fogelman graduated from medical school in 1998, 28 years ago.
Does Dr. David R. Fogelman do research?
Dmand AI links 122 publications to Dr. Fogelman, published from 2008 to 2025. Dr. Fogelman has worked on 5 clinical trials.
Who does Dr. David R. Fogelman publish with?
Dr. Fogelman's most frequent co-authors are Milind Javle, MD (39 shared papers), Robert A. Wolff, MD (31 shared papers) and Michael J. Overman, MD (23 shared papers).
Selling to hematology and oncology practices?
See hematologists and oncologists in Michigan by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card